Get the Stockscreener App
30.79
1.22%
-0.35
ARK Genomic Revolution ETF stock is traded at $30.79, with a volume of 707.99K.
It is down -1.22% in the last 24 hours and down -3.51% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$31.14
Open:
$31.115
24h Volume:
707.99K
Relative Volume:
0.21
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+12.84%
1M Performance:
-3.51%
6M Performance:
+47.04%
1Y Performance:
+23.83%
1-Day Range:
$30.70
$31.19
1-Week Range:
$27.11
$31.19
52-Week Range:
$17.50
$34.06
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
30.77 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
334.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
680.79 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
257.77 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
615.22 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Is ARK Genomic Revolution ETF stock overpriced at current multiplesJuly 2025 Summary & Free Long-Term Investment Growth Plans - newser.com
Trading the Move, Not the Narrative: (ARKG) Edition - news.stocktradersdaily.com
Will ARK Genomic Revolution ETF stock sustain bullish trend into 2025 - newser.com
Why Tempus AI Stock Is Plunging This Week - AOL.com
Will ARK Genomic Revolution ETF stock beat growth indexesJuly 2025 Analyst Calls & Safe Capital Allocation Plans - newser.com
Why ARK Genomic Revolution ETF stock could be next leaderAnalyst Upgrade & Weekly High Conviction Ideas - newser.com
Why analysts raise outlook for ARK Genomic Revolution ETF stockWeekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Cathie Wood Snaps Up Kodiak AI and Intellia Stocks, Offloads Roblox and Kratos Shares - MSN
Can ARK Genomic Revolution ETF stock surprise with quarterly results2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
P 500 performance this yearJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Is ARK Genomic Revolution ETF stock nearing a technical breakoutWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
Buy on the Dip Prospects: November 12 Edition - ETF Database
Trending Industry Today: ARK Innovation ETF Leads Losses In ARK ETFs Stocks - 富途牛牛
ARKG January 2026 Options Begin Trading - Nasdaq
How reliable is ARK Genomic Revolution ETF stock dividend growthMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
ARK Genomic Revolution ETF (NYSE:ARKG) Stock Quote - FinancialContent
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.79%
Cap:
|
Volume (24h):